Skip to search.
 TSX Up 1.01% TSX Ventures Down 0.27%

Geron Corporation (GERN)

-NasdaqGS
4.09 Down 0.13(3.08%) 1:51PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:4.22
Open:4.27
Bid:4.08 x 18200
Ask:4.09 x 2500
1y Target Est:5.50
Beta:1.53
Next Earnings Date:N/A
Day's Range:4.08 - 4.30
52wk Range:1.76 - 4.67
Volume:1,061,737
Avg Vol (3m):2,354,290
Market Cap:646.58M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 3.08%646.58M
BMYDown 0.25%107.55B
GSKUp 2.35%103.10B
NVSUp 0.91%250.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):548.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.07
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-12.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback